To collect, process, store, and study biological samples and related clinical and imaging data from participants with known or suspected urothelial carcinoma or another related malignancy of the urinary tract.
Age 18 years or older at the time of consent.
Known or suspected urothelial carcinoma or other related malignancy of the urinary tract for which biospecimen and associated clinical data collection is relevant to the objectives of this protocol. This may include patients undergoing diagnostic evaluation for a lesion, mass, abnormal cytology, or other clinical finding concerning for malignancy.
Undergoing evaluation, treatment, surveillance, follow-up care, or clinically indicated procedures at The University of Texas M.D. Anderson Cancer Center, including Houston Area Locations.
Able to understand and personally provide informed consent.
Age younger than 18 years.
Unable to understand the study information or unable to personally provide informed consent.
Declines participation.
No known or suspected urothelial carcinoma or other related malignancy of the urinary tract, and no clinical circumstance in which enrollment under this protocol is relevant to the study objectives.
UT MD Anderson Cancer Center
Cohort
Prospective
biospecimen Collection
Diagnostic testbiospecimen collection during routine care encounters or clinically indicated procedures
Overall Survival
Click on the lead sponsor to view all of their trials.
